Cardior Pharmaceuticals

Next Generation RNA based Cardiovascular Medicine

Winner of the Startup Challenge at Deutsche Biotechnologietage 2017!

Today, Cardior has been selected as Winner of the Startup Challenge at Deutsche Biotechnologietage 2017!
10 companies were selected to pitch in this competition sponsored by Johnson & Johnson and JJI.

The award includes one-year access to JLINX incubator in Beerse, Belgium including mentoring by experts from Johnson & Johnson Innovation and its network.
In addition, Bioqube Ventures offers access to a Seedfund they are managing for JJI.

Cardior Award_2017